Latest Breaking News On - Sergey jakimov - Page 1 : comparemela.com

Longevity, Aging Drugs: Treatments Could Take Years Investors Are Pouring Billions Into Them

Biotech start-ups are trying to use that knowledge to keep people healthier as they grow older with the aim of eventually extending the human life span

Alex colvilleJim mellonJeff bezosNeal templinKristen fortneySergey jakimovEli lillyPhil newmanEric verdinAmol sarvaLongevity technologyBuck institute for research onLongevity technology newmanAltos labsEditor in chief phil newmanIncarda therapeutics

Venture Capital Giants In The Billion-Dollar Quest For Longevity Breakthroughs

These globally distributed VC funds and grant programs are reshaping the future of healthcare, and by investing in them, they re increasing our chances of paving the w.

Baden wübergUnited statesCzech republicCity ofUnited kingdomChannel islandsSan franciscoNew yorkRegion flamandeGarri zmudzeDeclan dooganRobert nelsonPetr sramekNils reggeAmol sarvaInaki berenguer

Secondary Use Of Primary Health Data In A Clinical Trials Digital Revolution

Secondary Use Of Primary Health Data In A Clinical Trials Digital Revolution
clinicalleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicalleader.com Daily Mail and Mail on Sunday newspapers.

Sergey jakimovHealth data symbiosis withHealth dataPubmed central

Beyond Biotech podcast 21: CanSinoBIO, HTID, Longevity Science Foundation

This week our podcast guests are from the HTFC, LongeVC, the Longevity Science Foundation, CanSinoBIO and JLL.

France generalComunidad autonoma de catalunaPierre morgonJean denis shuSergey jakimovTravis mccreadyCansino biologicsConvidecia air at world vaccine congressCansino biologics incLongevity science foundationPierre corneilleHealthtech innovation daysTech innovation daysHealthtech for careSino biologicsConvidecia air

Want to live longer? Take up the challenge of this Riga VC fund

Want to live longer? Take up the challenge of this Riga VC fund April 27, 2021 Riga-based 35 million euro longevity-focused venture capital fund LongeVC launched an in-house acceleration programme for professionals with education and work experience in the biotech industry, aiming to create high-quality startup teams. “The venture capital fund LongeVC has created its own accelerator. This means that from time to time LongeVC will define verticals that we see the biggest potential in.” LongeVC venture capital fund partner Sergey Jakimov Applications will be selected on a rolling basis. Applicants should fill in a form on the LongeVC website to prove their expertise in the field.

Sergey jakimovLongevity incAubrey de greyDeep longevityAdjunct professorBuck instituteAging alexநீண்ட ஆயுள் இன்க்ஆப்ரி டி சாம்பல்ஆழமான நீண்ட ஆயுள்பக் நிறுவனம்